CoChat

Ustekinumab in the Treatment of Severe Atopic Dermatitis: A Preliminary Report of Our Experience With 4 Patients

Open access
Fernández-Antón Martínez, M.C., Alfageme Roldán, F., Ciudad Blanco, C., Suárez Fernández, R. · 2014 · Actas Dermo-Sifiliográficas (English Edition)
Cited by 39

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

4 Patients ଝ Ustekinumab en el tratamiento de la dermatitis atópica severa.Nuestra experiencia en 4 pacientes.Informe preliminarTable 1 Summary of the Epidemiological, Clinical, and Therapeutic Characteristics of our Patients.Patient 1 Patient 2 Patient 3 Patient 4 Age 28 29 29 23 Onset of AD Childhood Childhood Childhood Childhood Hay fever Yes Yes Yes Yes Asthma No Yes Yes No Sex Male Male Male

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.adengl.2013.05.005

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 5

  1. Puya, 2012, Treatment of severe refractory adult atopic dermatitis with ustekinumab, Int J Dermatol, 51, 115, 10.1111/j.1365-4632.2011.05195.x · DOI · Paper page
  2. Koutruba, 2010, Review of ustekinumab, an interleukin-12 and interleukin-23 inhibitor used for the treatment of plaque psoriasis, Ther Clin Risk Manag, 6, 123
  3. Kikly, 2006, The IL-23/Th17 axis: Therapeutic targets for autoimmune inflammation, Curr Opin Immunol, 18, 670, 10.1016/j.coi.2006.09.008 · DOI · Paper page
  4. Steward-Tharp, 2010, New insights into T cell biology and T cell-directed therapy for autoimmunity, inflammation, and immunosuppression, Ann N Y Acad Sci., 1183, 123, 10.1111/j.1749-6632.2009.05124.x · DOI
  5. Coondoo, 2009, Biologics in dermatology therapy, an update, Indian J Dermatol, 54, 211, 10.4103/0019-5154.55627 · doi:10.4103/0019-5154.55627

Cited by

See all 39

Metadata

Authors
Fernández-Antón Martínez, M. C., Alfageme Roldán, F., Ciudad Blanco, C., & Suárez Fernández, R.
Venue
Actas Dermo-Sifiliográficas (English Edition)
Publisher
Elsevier BV
Published
2014-04
Volume
105
Issue
3
Pages
312-313
ISSN
  • 0001-7310 (ISSN-L)
  • 1578-2190
OpenAlex
W1964391451
Cited by
39
References
1
FWCI
8.42
Type
journal article
Language
en
Open access
hybrid
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Ustekinumab in the Treatment of Severe Atopic Dermatitis: A Preliminary Report of Our Experience With 4 Patients. https://app.cochat.ai/papers/10.1016/j.adengl.2013.05.005
The paper
Fernández-Antón Martínez, M. C., Alfageme Roldán, F., Ciudad Blanco, C., & Suárez Fernández, R. (2014). Ustekinumab in the Treatment of Severe Atopic Dermatitis: A Preliminary Report of Our Experience With 4 Patients. Actas Dermo-Sifiliográficas (English Edition). https://doi.org/10.1016/j.adengl.2013.05.005

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.